Jefferies Group LLC Iovance Biotherapeutics, Inc. Transaction History

Jefferies Group LLC

$10.2 Billion
Q3 2022

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 21, 2023	SELL	$6.38 - $18.33 $101,665 - $292,088	-15,935 Reduced 99.25%	121 $1,000
Q2 2022 Aug 15, 2022	BUY	$6.38 - $18.33 $49,783 - $143,028	7,803 New	7,803 $18,000
Q1 2022 May 16, 2022	SELL	$12.38 - $19.1 $198,773 - $306,669	-16,056 Closed	0 $0
Q4 2021 Sep 21, 2023	SELL	$16.55 - $27.63 $5.86 Million - $9.79 Million	-354,204 Reduced 95.66%	16,056 $306,000
Q4 2021 Feb 14, 2022	BUY	$16.55 - $27.63 $265,726 - $443,627	16,056 New	16,056 $307,000
Q3 2021 Nov 15, 2021	SELL	$20.35 - $26.63 $7.53 Million - $9.86 Million	-370,260 Closed	0 $0
Q2 2021 Sep 21, 2023	BUY	$16.33 - $33.07 $5.74 Million - $11.6 Million	351,760 Added 1901.41%	370,260 $9.63 Million
Q2 2021 Aug 16, 2021	BUY	$16.33 - $33.07 $5.74 Million - $11.6 Million	351,760 Added 1901.41%	370,260 $9.63 Million
Q1 2021 Sep 21, 2023	SELL	$28.67 - $52.59 $13.2 Million - $24.2 Million	-460,000 Reduced 96.13%	18,500 $585,000
Q1 2021 May 14, 2021	SELL	$28.67 - $52.59 $13.2 Million - $24.2 Million	-460,000 Reduced 96.13%	18,500 $586,000
Q4 2020 Sep 21, 2023	BUY	$28.04 - $50.26 $13.4 Million - $24 Million	478,500 New	478,500 $22.2 Million
Q4 2020 Feb 16, 2021	BUY	$28.04 - $50.26 $13.4 Million - $24 Million	478,500 New	478,500 $22.2 Million
Q3 2020 Nov 13, 2020	SELL	$27.75 - $36.3 $270,756 - $354,179	-9,757 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$27.21 - $41.0 $1.68 Million - $2.54 Million	-61,871 Reduced 86.38%	9,757 $268,000
Q1 2020 May 15, 2020	BUY	$19.54 - $38.85 $1.39 Million - $2.76 Million	71,128 Added 14225.6%	71,628 $2.14 Million
Q4 2019 Feb 13, 2020	SELL	$17.95 - $29.41 $284,238 - $465,707	-15,835 Reduced 96.94%	500 $14,000
Q3 2019 Nov 13, 2019	BUY	$17.99 - $26.0 $293,866 - $424,710	16,335 New	16,335 $297,000
Q2 2018 Aug 14, 2018	SELL	$12.45 - $16.95 $311,250 - $423,750	-25,000 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$8.1 - $19.5 $202,500 - $487,500	25,000 New	25,000 $423,000

Others Institutions Holding IOVA

# of Institutions

316

Shares Held

244M

Call Options Held

3.77M

Put Options Held

1.7M

View Full List

About IOVANCE BIOTHERAPEUTICS, INC.

Ticker IOVA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 157,800,992
Market Cap $898M
Description
Iovance Biotherapeutics, Inc., a clinical-stage biotechnology company, focuses on developing and commercializing cancer immunotherapy products to harness the power of a patient's immune system to eradicate cancer cells. It has six ongoing phase 2 clinical studies, including C-144-01, of its lead product candidate, lifileucel, for the treatment o...

More about IOVA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jefferies Group LLC with notifications on news.

Account